Post job

Blueprint Medicines overview

Industry
Biotechnology
Revenue
Headquarters
Employees
495
Founded in
Website
Organization type
Public
Social media
Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation™ Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat. Founded in 2011 by a proven team of scientists and entrepreneurs with world-renowned expertise in the development of targeted cancer therapies, cancer genomics, and rational drug development, Blueprint Medicines is poised to realize the promise of the cancer data “revolution”: truly personalized therapies that improve outcomes and shift cancer to a manageable condition.
Based in Cambridge, MA, Blueprint Medicines is a medium-sized health care company with 495 employees and a revenue of $508.8M.

Blueprint Medicines's mission statement

Blueprint medicines aims to make real the promise of precision therapy to improve and extend life for as many people with cancer and hematologic disorders as possible.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Blueprint Medicines employee reviews

Be the first to review!

Do you work at Blueprint Medicines?

Help job seekers learn about working at Blueprint Medicines

Job openings at Blueprint Medicines
15 positions

On this page

Be the first to review Blueprint Medicines

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Blueprint Medicines?

The team at Blueprint Medicines

  • The founders of Blueprint Medicines are Nicholas B. Lydon, Alexis A. Borisy and Brian Druker.
  • The key people at Blueprint Medicines are Jeffrey W. Albers, Nicholas B. Lydon and Alexis A. Borisy.
Key people
Jeffrey W. Albers
Nicholas B. Lydon
Alexis A. Borisy
Brian Druker

Blueprint Medicines rankings

Blueprint Medicines is ranked #92 on the Best Health Care companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Blueprint Medicines salaries

Average Blueprint Medicines salary
$84,447
yearly
$40.60 hourly
Updated March 14, 2024

Rate Blueprint Medicines' promotion and raise policies.

Zippia waving zebra

Do you work at Blueprint Medicines?

Is Blueprint Medicines' workforce diverse and inclusive?

Blueprint Medicines financial performance

9.4
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Blueprint Medicines currently has 204.0M in revenue. Blueprint Medicines's most recent quarter produced 56.6m (q3'2023).

Blueprint Medicines annual revenue

$794M
$635M
$476M
$317M
$159M
$0
2019
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at Blueprint Medicines?

Claiming and updating your company profile on Zippia is free and easy.

Blueprint Medicines FAQs

Search for jobs

Most common locations at Blueprint Medicines

Zippia gives an in-depth look into the details of Blueprint Medicines, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Blueprint Medicines. The employee data is based on information from people who have self-reported their past or current employments at Blueprint Medicines. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Blueprint Medicines. The data presented on this page does not represent the view of Blueprint Medicines and its employees or that of Zippia.

Blueprint Medicines may also be known as or be related to BLUEPRINT MEDICINES CORP, Blueprint Medicines, Blueprint Medicines Corp, Blueprint Medicines Corp. and Blueprint Medicines Corporation.